Search research articles
Contact Us
Filters
Showing results (661-670 of 698) with videos related to
Page
of 70
Sort By:
Cancer
|
April 7, 2025
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial
Hannah Goulart, Hagop Kantarjian, Gautam Borthakur, et al.
Brain Research
|
June 12, 2024
Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice
Matthew L Russo, Gelique Ayala, Demetria Neal, et al.
The Lancet. Haematology
|
September 20, 2024
Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial
Nicholas J Short, Daniel Nguyen, Elias Jabbour, et al.
American Journal of Hematology
|
May 15, 2023
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1
Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Cancer
|
April 9, 2024
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia
Elias Jabbour, Fadi G Haddad, Koji Sasaki, et al.
American Journal of Hematology
|
January 5, 2023
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results
Hagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
American Journal of Hematology
|
January 23, 2023
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors
Elias J Jabbour, Koji Sasaki, Fadi G Haddad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL
Hagop Kantarjian, Nicholas J Short, Fadi G Haddad, et al.
American Journal of Hematology
|
December 24, 2024
Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation
Jayastu Senapati, Hagop M Kantarjian, Fadi G Haddad, et al.
Annales De Cardiologie Et D'Angeiologie
|
September 23, 2019
[An independent observatory in Vendée on ST-elevated acute myocardial infarction (the OVISCA Register). A Departmental evaluation of demographic trends, mortality and delays before treatment]
E Boiffard, J Dimet, O Baron, et al.
Page
of 70
Search research articles
Search
Showing results (661-670 of 698) with videos related to
Sort By:
Page
of 70
Cancer
|
April 7, 2025
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial
Hannah Goulart, Hagop Kantarjian, Gautam Borthakur, et al.
Brain Research
|
June 12, 2024
Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice
Matthew L Russo, Gelique Ayala, Demetria Neal, et al.
The Lancet. Haematology
|
September 20, 2024
Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial
Nicholas J Short, Daniel Nguyen, Elias Jabbour, et al.
American Journal of Hematology
|
May 15, 2023
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1
Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Cancer
|
April 9, 2024
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia
Elias Jabbour, Fadi G Haddad, Koji Sasaki, et al.
American Journal of Hematology
|
January 5, 2023
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results
Hagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
American Journal of Hematology
|
January 23, 2023
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors
Elias J Jabbour, Koji Sasaki, Fadi G Haddad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL
Hagop Kantarjian, Nicholas J Short, Fadi G Haddad, et al.
American Journal of Hematology
|
December 24, 2024
Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation
Jayastu Senapati, Hagop M Kantarjian, Fadi G Haddad, et al.
Annales De Cardiologie Et D'Angeiologie
|
September 23, 2019
[An independent observatory in Vendée on ST-elevated acute myocardial infarction (the OVISCA Register). A Departmental evaluation of demographic trends, mortality and delays before treatment]
E Boiffard, J Dimet, O Baron, et al.
Page
of 70